KalVista Pharmaceuticals (KALV) Cash from Operations (2014 - 2025)
KalVista Pharmaceuticals recorded quarterly Cash from Operations of 54502000.0 in Q3 2025, down 35.03% quarter-over-quarter from 40364000.0 in Q2 2025, and down 35.51% year-over-year from 84511929.99 in Q3 2024.
KalVista Pharmaceuticals' Cash from Operations history runs 12 years deep, the most recent figure standing at 54502000.0 for Q3 2025.
- In Q3 2025, Cash from Operations fell 35.51% year-over-year to 54502000.0; the TTM figure through Jul 2025 stood at 174728000.0 (down 70.1% YoY), while the FY2025 annual figure was 152907000.0, down 71.36% from the prior year.
- Cash from Operations came in at 54502000.0 for Q3 2025 at KalVista Pharmaceuticals, down from 40364000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 7586000.0 in Q1 2021 to a low of 54502000.0 in Q3 2025.
- A 5-year average of 24221388.89 and a median of 21615000.0 in 2022 frame the typical range for Cash from Operations.
- On a YoY basis, Cash from Operations climbed as much as 42.13% in 2021 and fell as far as 394.29% in 2021.
- KalVista Pharmaceuticals' Cash from Operations stood at 19545000.0 in 2021, then fell by 5.37% to 20594000.0 in 2022, then grew by 3.73% to 19825000.0 in 2023, then plunged by 99.96% to 39642000.0 in 2024, then tumbled by 37.49% to 54502000.0 in 2025.
- According to Business Quant data, Cash from Operations over the past three periods registered 54502000.0, 40364000.0, and 39642000.0 for Q3 2025, Q2 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -1.67 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -12.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.49 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.43 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.08 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 70.50 Mn |
| 10 | KalVista Pharmaceuticals | 1.44 Bn | 1.25 Bn | 56.41 Mn | -54.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2025 | -54.50 Mn |
| Jul 31, 2025 | -54.50 Mn |
| Apr 30, 2025 | -40.36 Mn |
| Apr 30, 2025 | -40.36 Mn |
| Oct 31, 2024 | -39.64 Mn |
| Oct 31, 2024 | -39.64 Mn |
| Jul 31, 2024 | -40.22 Mn |
| Jul 31, 2024 | -40.22 Mn |
| Apr 30, 2024 | -15.11 Mn |
| Apr 30, 2024 | -15.11 Mn |
| Jan 31, 2024 | -27.57 Mn |
| Jan 31, 2024 | -27.57 Mn |
| Oct 31, 2023 | -19.83 Mn |
| Oct 31, 2023 | -19.83 Mn |
| Jul 31, 2023 | -26.73 Mn |
| Jul 31, 2023 | -26.73 Mn |
| Apr 30, 2023 | -22.64 Mn |
| Apr 30, 2023 | -22.64 Mn |
| Jan 31, 2023 | -9.29 Mn |
| Jan 31, 2023 | -9.29 Mn |
| Oct 31, 2022 | -20.59 Mn |
| Oct 31, 2022 | -20.59 Mn |
| Jul 31, 2022 | -22.74 Mn |
| Jul 31, 2022 | -22.74 Mn |
| Apr 30, 2022 | -26.79 Mn |
| Apr 30, 2022 | -26.79 Mn |
| Jan 31, 2022 | -14.07 Mn |
| Jan 31, 2022 | -14.07 Mn |
| Oct 31, 2021 | -19.55 Mn |
| Oct 31, 2021 | -19.55 Mn |
| Jul 31, 2021 | -17.74 Mn |
| Jul 31, 2021 | -17.74 Mn |
| Apr 30, 2021 | -11.05 Mn |
| Apr 30, 2021 | -11.05 Mn |
| Jan 31, 2021 | -7.59 Mn |
| Jan 31, 2021 | -7.59 Mn |
| Oct 31, 2020 | -7.95 Mn |
| Oct 31, 2020 | -7.95 Mn |
| Jul 31, 2020 | -3.59 Mn |
| Jul 31, 2020 | -3.59 Mn |
| Apr 30, 2020 | -12.62 Mn |
| Apr 30, 2020 | -12.62 Mn |
| Jan 31, 2020 | -13.11 Mn |
| Jan 31, 2020 | -13.11 Mn |
| Oct 31, 2019 | -7.81 Mn |
| Oct 31, 2019 | -7.81 Mn |
| Jul 31, 2019 | -11.28 Mn |
| Jul 31, 2019 | -11.28 Mn |
| Apr 30, 2019 | -10.51 Mn |
| Apr 30, 2019 | -10.51 Mn |
| Jan 31, 2019 | -10.86 Mn |
| Jan 31, 2019 | -10.86 Mn |
| Oct 31, 2018 | -8.79 Mn |
| Oct 31, 2018 | -8.79 Mn |
| Jul 31, 2018 | -6.21 Mn |
| Jul 31, 2018 | -6.21 Mn |
| Apr 30, 2018 | -5.96 Mn |
| Apr 30, 2018 | -5.96 Mn |
| Jan 31, 2018 | 28.22 Mn |
| Jan 31, 2018 | 28.22 Mn |
| Oct 31, 2017 | -7.26 Mn |
| Oct 31, 2017 | -7.26 Mn |
| Jul 31, 2017 | -4.45 Mn |
| Jul 31, 2017 | -4.45 Mn |
| Apr 30, 2017 | -2.64 Mn |
| Apr 30, 2017 | -2.64 Mn |
| Jan 31, 2017 | -11.24 Mn |
| Jan 31, 2017 | -11.24 Mn |
| Oct 31, 2016 | -4.19 Mn |
| Oct 31, 2016 | -4.19 Mn |
| Jul 31, 2016 | -5.65 Mn |
| Jul 31, 2016 | -5.65 Mn |
| Mar 31, 2016 | -5.08 Mn |
| Mar 31, 2016 | -5.08 Mn |
| Dec 31, 2015 | -5.07 Mn |
| Dec 31, 2015 | -5.07 Mn |
| Sep 30, 2015 | -5.31 Mn |
| Sep 30, 2015 | -5.31 Mn |
| Jun 30, 2015 | -6.44 Mn |
| Jun 30, 2015 | -6.44 Mn |
| Mar 31, 2015 | -4.05 Mn |
| Mar 31, 2015 | -4.05 Mn |
| Sep 30, 2014 | -3.22 Mn |
| Sep 30, 2014 | -3.22 Mn |
| Jun 30, 2014 | -1.94 Mn |
| Jun 30, 2014 | -1.94 Mn |
| Mar 31, 2014 | -1.75 Mn |
| Mar 31, 2014 | -1.75 Mn |